STRAUMANN N (STMN.SW) Financials
STMN.SW Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 3.4 billion | 1.6 billion |
2023-06-30 | 3.4 billion | 1.5 billion |
2023-03-31 | 843.4 million | 379.9 million |
2022-12-31 | 3.5 billion | 1.6 billion |
STMN.SW Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 206.3 million | -117.4 million |
2023-06-30 | 110.1 million | 8.4 million |
2023-03-31 | 54.9 million | 3.5 million |
2022-12-31 | 142.4 million | 6.6 million |
STMN.SW Net Income
Date | Net Income |
---|---|
2023-12-31 | 40.3 million |
2023-06-30 | 205.8 million |
2023-03-31 | 108.7 million |
2022-12-31 | 169.4 million |
STMN.SW Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 413.5 million | - | 212.4 million |
2023-06-30 | 603.1 million | 399.9 million | - |
2023-03-31 | 174.3 million | - | - |
2022-12-31 | 697.1 million | 395.0 million | 221.7 million |
STMN.SW Shares Outstanding
STMN.SW Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 103.0 million | - | - | - |
2023-06-30 | 86.4 million | - | 389.1 million | 217.5 million |
2023-03-31 | 48.9 million | - | 306.1 million | 110.7 million |
2022-12-31 | 107.4 million | 104.6 million | 412.3 million | 226.0 million |
STMN.SW Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.2 billion | 332.9 million |
2023-06-30 | 1.2 billion | 305.9 million |
2023-03-31 | 580.2 million | 141.5 million |
2022-12-31 | 1.1 billion | 331.7 million |
STMN.SW
Price: CHF116.90
Dividend Yield: 0.01%
Forward Dividend Yield: 0.34%
Payout Ratio: 25.97%
Dividend Per Share: 0.40 CHF
Earnings Per Share: 1.54 CHF
P/E Ratio: 59.23
Exchange: EBS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 291058
Market Capitalization: 22.1 billion
Average Dividend Frequency: 1
Years Paying Dividends: 26
DGR3: 11.97%
DGR5: -8.72%
DGR10: 30.00%
DGR20: 30.00%